---
schema_version: "secwatch.filing_event.v1"
accession: "0002007919-26-000002"
form_type: "8-K"
ticker: "INBX"
cik: "0002007919"
company_name: "Inhibrx Biosciences, Inc."
filed_at: "2026-02-23T23:59:59+00:00"
generated_at: "2026-05-16T01:16:38.429578+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Inhibrx publishes updated corporate presentation on investor website

## Summary
- Presentation posted February 23, 2026 under the Investors tab of www.inhibrx.com.
- Filing includes only presentation disclaimer; substantive pipeline and financial details not accessible in this report.
- Company routinely updates this presentation for conferences and meetings; no specific material changes disclosed.

## SEC filing metadata
- accession: 0002007919-26-000002
- form_type: 8-K
- ticker: INBX
- cik: 0002007919
- company_name: Inhibrx Biosciences, Inc.
- filed_at: 2026-02-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2007919/000200791926000002/0002007919-26-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2007919/000200791926000002/inhibrx-20260223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0002007919-26-000002
- JSON: https://secwatch.observer/filing/0002007919-26-000002.json
- Plain text: https://secwatch.observer/filing/0002007919-26-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.